Merck KGaA (OTCMKTS:MKKGY) Research Coverage Started at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Merck KGaA (OTCMKTS:MKKGYFree Report) in a research note issued to investors on Thursday morning, Marketbeat.com reports. The firm issued a buy rating on the stock.

Merck KGaA Trading Down 5.6 %

MKKGY stock opened at $35.23 on Thursday. Merck KGaA has a 12-month low of $28.59 and a 12-month high of $39.17. The company has a 50 day moving average of $36.43 and a two-hundred day moving average of $35.02.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.